Ram Kuwar, Xuejun Wen, Ning Zhang, Dong Sun,
Abstract Neovascularization and angiogenesis in the brain are important physiological processes for normal brain development and repair/regeneration following insults.Integrins are cell surface adhesion receptors mediating important function of cells such as survival, growth and development during tissue organization,differentiation and organogenesis.In this study, we used an integrin-binding array platform to identify the important types of integrins and their binding peptides that facilitate adhesion, growth, development, and vascular-like network formation of rat primary brain microvascular endothelial cells.Brain microvascular endothelial cells were isolated from rat brain on post-natal day 7.Cells were cultured in a custom-designed integrin array system containing short synthetic peptides binding to 16 types of integrins commonly expressed on cells in vertebrates.After 7 days of culture, the brain microvascular endothelial cells were processed for immunostaining with markers for endothelial cells including von Willibrand factor and platelet endothelial cell adhesion molecule.5-Bromo-2′-dexoyuridine was added to the culture at 48 hours prior to fixation to assess cell proliferation.Among 16 integrins tested, we found that α5β1, αvβ5 and αvβ8 greatly promoted proliferation of endothelial cells in culture.To investigate the effect of integrin-binding peptides in promoting neovascularization and angiogenesis, the binding peptides to the above three types of integrins were immobilized to our custom-designed hydrogel in three-dimensional (3D)culture of brain microvascular endothelial cells with the addition of vascular endothelial growth factor.Following a 7-day 3D culture, the culture was fixed and processed for double labeling of phalloidin with von Willibrand factor or platelet endothelial cell adhesion molecule and assessed under confocal microscopy.In the 3D culture in hydrogels conjugated with the integrin-binding peptide, brain microvascular endothelial cells formed interconnected vascular-like network with clearly discernable lumens, which is reminiscent of brain microvascular network in vivo.With the novel integrin-binding array system, we identified the specific types of integrins on brain microvascular endothelial cells that mediate cell adhesion and growth followed by functionalizing a 3D hydrogel culture system using the binding peptides that specifically bind to the identified integrins, leading to robust growth and lumenized microvascular-like network formation of brain microvascular endothelial cells in 3D culture.This technology can be used for in vitro and in vivo vascularization of transplants or brain lesions to promote brain tissue regeneration following neurological insults.
Key Words: 3D culture; angiogenesis; brain microvascular endothelial cells; hydrogel; integrins; platelet endothelial cell adhesion molecule (PECAM-1); vascular endothelial growth factor (VEGF); vascularization
Neurovascular dysfunction resulting from cerebrovascular and neurological disorders or brain trauma features complicated pathological mechanisms.Angiogenesis plays a critical role in regeneration process in neurological diseases.Neovascularization and angiogenesis are characterized by remodeling of the extracellular matrix (ECM), proliferation and migration of vascular endothelial cells (ECs) followed by lumen formation and functional maturation, and these processes require adhesive molecules such as integrins (Pulous and Petrich, 2019).Studies have shown that ECM maintains adhesive interactions with integrins that are expressed on the surface of ECs facilitating neovascularization (Kant et al., 2019; Edwards et al., 2020; Mo,2021).Integrins are the major class of ECM receptors that are present on cell surfaces as αβ heterodimers (Hynes et al., 1999).To date, 18 types of α subunits and eight types of β subunits have been recognized, giving rise to 20 recognized αβ dimers with different specificity (Hynes et al., 1999).The instructive role of integrins in angiogenesis at both developmental and pathological conditions has been demonstrated in studies of genetic ablation and conditional deletion of integrin related genes (Gustafsson and Fassler, 2000; Hou et al., 2020; Zhang et al., 2022).Because of their crucial role in angiogenesis, integrins are often targeted for the treatment of malignant growth using antagonists (Rocha et al., 2018; Hou et al., 2020).Among integrin family members, several of them are particularly associated with angiogenesis.Studies have reported that ECs express higher levels of integrins αvβ3 and α5β1 following stimulation with growth factors or proangiogenic signaling molecules (Brooks et al., 1994; Kim et al., 2000a,b; Dudvarski Stankovic et al., 2018).Moreover, the binding of integrin with its ligands has been shown to trigger the intracellular cascades that lead to neovascularization and angiogenesis (Karimi et al., 2018), suggesting binding with the proper ligands is crucial for the generation of cell signaling for angiogenesis.Additionally, recent studies have shown that short peptides,called integrin-binding peptides, bind specifically to the integrin, initiating the signaling for angiogenesis (Conibear et al., 2017; Jiang et al., 2019).
As the initial step toward brain tissue regeneration following neurological disorders, reconstructing the vascular network of primary brain microvascular endothelial cells (BMECs) is the key.Available strategies to engineer vascular network of BMECs are heavily relied upon Matrigel, a solubilized basement membrane matrix with heterogeneous composition derived from mouse sarcoma cells.Matrigel supports complex cellular behavior that is otherwise difficult to observe under regular laboratory conditions.For examples, ECs grown on Matrigel coated surfaces can form intricate network structure typical of microvascular network seenin vivo
(Kastana et al., 2019).However,mouse tumor origin and heterogeneous composition of Matrigel make it impossible for clinical translation.As an alternative, we have previously developed an integrin-binding array system which allows scholars to recognize the specific types of integrins and their binding peptides that can best support the growth of cell types of interest (Jiang et al., 2019).The integrin-binding array is created by immobilizing short synthetic peptides that exclusively bind to 16 types of integrins commonly expressed on cells of vertebrates on a 48-well cell culture plate (Jiang et al., 2019).This array system can help to identify the key types of integrins and their binding peptides that mediate cell adhesion and growth.Using this array, we have identified integrin peptides that are supportive for optimal growth of several types of primary cells from human and animals that are known difficult to culture on regular culture wares, including human induced pluripotent stem cells (hiPSCs), hiPSC-derived neuroepithelial progenitors (NEPs), and rat primary cortical neurons(Jiang et al., 2019; Kuwar et al., 2020).Vascularization is the key step for initiation of brain regeneration following neurological injures.To facilitate this process, it is necessary to identify factors that can stimulate the optimal growth of BMECs.In this study, we assessed the growth of primary rat BMECs isolated from the cortical region of 7-dayold rat pups on the integrin-binding array.To further confirm the supporting effect of integrin binding peptide on BMEC growth, we also immobilized the identified integrin-binding peptides and vascular endothelial growth factor(VEGF) peptides in a synthetic hydrogel for three-dimensional (3D) culture of BMECs.
ad libitum
.g
for 10 minutes at 4°C,were collected and seeded in rat tail type I collagen coated flasks with the Complete Rat Endothelial Cell Medium (Cat# M1266, Cell Biologics, Chicago,IL, USA).Cells were passaged when they were 80–90% confluent.Rat primary ECs at passages 2–4 were used for this study.A total of 30,000 cells/well were seeded in the 48-well integrin-binding array platform according to our published protocol (Jiang et al., 2019), and cultured in the endothelial cell culture medium with supplement of fetal bovine serum,epidermal growth factor and VEGF for a 7-day culture with the media changed every 48 hours.To assess the proliferation rate, thymidine analog 5-bromo-2′-dexoyuridine (BrdU, 10 μM) was added to the complete rat endothelial cell medium (Cat# M1266, Cell Biologics) at day 5 for 48 hours.Cells that grew in collagen coated wells served as control.After a 7-day culture, the ECs were fixed for 30 minutes with 4% paraformaldehyde followed by immunostaining.
After 30 minutes of fixation, ECs cells were thoroughly washed with PBS followed by a 1-hour serum blocking with 10% normal horse serum (Thermo Fisher Scientific, Waltham, MA, USA) before incubation with the primary antibodies.The primary antibodies used included platelet endothelial cell adhesion molecule (PECAM-1) mouse anti-rat monoclonal antibody (1:500,Cat# MCA1334, Bio-Rad, Hercules, CA, USA) and von Willebrand factor(VWF) polyclonal antibody (rabbit) (1:1000, Cat# bs-0586R, Bioss, Boston,MA, USA) to label EC cells, and mouse anti-rat BrdU (1:200, Cat# MCA6144,Bio-Rad) to labeling proliferating cells.Following overnight incubation at 4°C with agitation, the ECs were washed with PBS to remove primary antibodies and then incubated with the secondary antibodies including Alexa Fluor 488 anti-mouse IgG (Cat# A11001) or Alexa Fluor 568 anti-rabbit IgG (Cat# A11036; both 1:200, Thermo Fisher Scientific) for 1 hour at room temperature on a shaker.After that, cells were washed with PBS and stained with 4′,6-diamidino-2-phenylindole (DAPI; 1:1000, Thermo Fisher Scientific)for 10 minutes, followed by PBS washes and quick rinse with dHO before coverslipped with Vectashield (Vestor Laboratories, Newark, CA, USA).
After assessing cell proliferation in our customer-designed integrin-binding array platform, the peptides that better supported for EC growth were added to a polyethylene glycol-based injectable hydrogel for tubule formation of ECs in a 3D culture according to previously reported method (Li et al.,2014; Kuwar et al., 2020).The experiment was done in triplicates using 48-well plates.Briefly, the wells were first coated with 30 μL of hydrogel and incubated for 30 minutes at 37°C before seeding at a density of 80,000/well.A 0.8% hydrogel was diluted to 50% with the selected integrin-binding peptides plus ECs in EC culture medium (Cell Biologics).The integrin-binding peptides stock solution (Sigma) was at 4 mg/mL in PBS and was diluted to 0.5 mg/mL as the final concentration in the culture.The components for 3D culture included ECs, selected integrin binding peptide, varying concentrations of recombinant VEGF (final concentration in each well: 0, 0.2, 0.5, 1, and 1.5 μg/μL), EC culture medium and hydrogel as above described.All components were thoroughly mixed up before being adding into the wells of the hydrogel pre-coated plate, 50 μL/well, and then incubated for 30 minutes at 37°C.Once the gel was fully set, 200 μL of complete endothelial culture medium described above was gently added.The culture was maintained for 7 days with medium changed every 48 hours.After the 7-day culture, the ECs were fixed with 4% paraformaldehyde before processed for immunostaining for PECAM-1 mouse anti-rat monoclonal antibody (1:500, Cat# MCA1334,Bio-Rad), incubated overnight at 4°C with agitation, washed with PBS, and incubated with Alexa Fluor 568 anti-rabbit IgG (1:200, Cat# A11036, Thermo Fisher Scientific) and Phalloidin Dylight 488 (phalloidin stains F-actin of cell cytoskeleton) (1:50, Cat# 21833, Thermo Fisher Scientific) for 1 hour at room temperature on a shaker.After that, cells were washed, stained with DAPI,and coverslipped with Vectashield as described above.
To assess the percentage of PECAM-1 or VWF stained cells, five fields per well were randomly selected and imaged with an inverted fluorescent microscope(1X71 Olympus, Olympus, Tokyo, Japan) at 20× objective.The number of PECAM-1, VWF, BrdUor DAPIcells in the culture wells of control condition and 7 integrin-binding peptides, including αβ, αβ, αβ, αβ, αβ, αβ,αβand αβ, that have the best cell growth were counted using ImageJ software version 1.53 (NIH, Bethesda, MD, USA).For cell proliferation, the ratio of VWF/BrdUwas calculated using the number of VMF/BrdU doublelabeled cells against the total number of DAPIcells.For 3D culture, images were taken using LSM 710 Zeiss confocal microscope (Carl Zeiss, Stuttgart,Germany).
in vitro
study, no statistical methods were used to predetermine sample sizes; however, our sample sizes were similar to those reported in previous publications (Jiang et al., 2019; Kuwar et al., 2020).All experiments were performed in triplicate.For data analysis with multiple group comparison, data were analyzed with one-way analysis of variance followed bypost hoc
test with Tukey’spost hoc
test.GraphPad Prism 7.0 software(GraphPad Software, San Diego, CA, USA, www.graphpad.com) was used and data were presented as the mean ± SEM.A level ofP
< 0.05 was considered statistically significant.In this study, we assessed the growth of primary brain endothelial cells in our custom-designed integrin-binding array system.This array platform contained short synthetic peptides binding to 16 types of integrins, including αβ,αβ, αβ, αβ, αβ, αβ, αβ, αβ, αβ, αβ, αβ, αβ, αβ, αβ, αβand αβ, which are commonly expressed on almost all cells in vertebrates.BMECs isolated from p7 rat brain cerebral cortex were grown in the integrinbinding array plate for 7 days.Using EC cell markers including VWF and PECAM-1, as well as nuclei marker DAPI, we found about 95% of cultured cells were VWF and PECAM-1 positive, suggesting the purity of ECs with our culture method.The assessment of growth of BMECs on the integrin-binding array platform with VWF and PECAM-1 immunostaining demonstrated that most of the integrin-binding peptides supported the attachment and survival of BMECs (Figure 1).
BMECs were cultured with thymidine analogue BrdU for 48 hours to assess their proliferation.Extensive VWF/BrdU double-labeled cells were found in all wells (Figure 2).Among 16 integrin-binding peptides, BMECs grown in the wells with several integrin-binding peptides including αβ, αβ, αvβ1, αβor αβhad a significantly higher percentage of VWF/BrdU double labeled cells than cells grown in the standard collagen coated cells, among them BMECs grew in αβhad the highest proliferation rate (Figure 3).Subsequently, αβwas used in the 3D culture studies.
To assess the effect of integrin peptide on promotion of BMECs growth,we tested αβ, αβand αβintegrin-binding peptides for the 3D culture based on the cell proliferation study.We found αβwas the best one, and therefore we selected αβ-binding peptide for the final 3D culture study.In this study, we first assessed different concentrations of αβintegrin binding peptide at the concentration of 0.2, 0.5, 1.0 or 1.5 μg/μL was mixed with the hydrogel and BMECs first, then the mixed components were added to the culture wells that were pre-coated with hydrogel.For the 3-D culture, the density of BMECs was at 80,000 cells/well.VEGF (0.2 μg/μL) was also added to the culture.After 7-day culture, we found that BMECs had the best growth in wells with αβintegrin binding peptide at 0.2 μg/μL but not in wells with higher concentrations.Taking 0.2 μg/μL as the optimal concentration for αβintegrin binding peptide, we then assessed different concentrations of VEGF for the growth of BMECs in 3D culture.VEGF was added to the 3D culture at 0.2, 0.5, 1.0 or 1.5 μg/μL.After 7-day culture, ECs were fixed and processed for immunostaining for PECAM-1, VWF or F-actin plus DAPI.We found that in the presence of VEGF at 1 μg/μL, BMECs had numerous sprouts-like structures from the main trunks spreading in the culture (Figure 4).The vascular-like network structures were positive for PECAM-1, F-actin and VWF, and lumen patency was assessed in x-y-z three planes with the Zen 2011 software (Figure 4).When BMECs grew in 3-D culture with αβ-binding peptide but without VEGF or with VEGF but without integrin binding peptide,no robust tubular formation or sprouting was observed.This finding suggests that αβ-binding peptide and VEGF work synergistically in promoting growth and interconnected and lumenized vascular-like ECs network formation of BMECs in the 3-D culture.
Figure 1|Growth of primary rat BMECs in the integrin-binding array platform.
Figure 2|Proliferation of primary rat BMECs in the integrin-binding array platform.
Figure 3 | Quantification analysis of the proliferation rate of the BMECs in the integrin-binding array platform.
Figure 4|Growth of primary rat BMECs in three-dimensional culture in integrin binding peptide-conjugated hydrogels.
The current study represents one of the first efforts to identify the specific types of integrins on the surface of BMECs that mediate their adhesion and growth in culture.By immobilizing to synthetic hydrogel in 3D culture the integrin-binding peptides that specifically bind to the identified integrins,we have achieved robust lumenized interconnected ECs network formation of BMECs in 3D culture in the hydrogel.The three types of integrins (αβ,αβand αβ) that were identified in the integrin-binding array platform are consistent with previous reports of integrin repertoire on primary ECs and their effect on EC function.In particular, the integrin αβwas implicated in endothelial cell chemotaxis and migration during angiogenesis(Li et al., 2006).In integrin α-deficient mice, a deficient angiogenesis was exhibited in response to cerebral hypoxia (Li et al., 2012), and triggered neuroinflammation (Kant et al., 2019).β-integrins were implicated in vascular lumen formation and vessel patterning (Bayless et al., 2000; Zovein et al.,2010; Yamamoto et al., 2015).Inhibition of β-integrins has led to pathological angiogenesis, accompanied by EC junctions weakening and blood leakage(Hynes, 2002; Yamamoto et al., 2015).In CNS angiogenesis, ECM fibronectin plays a strong angiogenic effect on ECs that is mediated by αβand αintegrins through the MAP kinase signaling pathway (Wang and Milner, 2006).Similarly, α-integrins including αβand αβfacilitate the growth and survival of newly forming blood vessels during angiogenesis and tissue remodeling for wound healing (Demircioglu and Hodivala-Dilke, 2016; Duro-Castano et al.,2017).The α-integrins belong to a family of RGD-binding integrins promoting distinct pathways of angiogenesis (Hood et al., 2003).For example, αβis required during VEGF-induced angiogenesis to activate focal adhesion kinase and Src kinase (Friedlander et al., 1995), while αβexpressed on glial cells regulates cerebrovascular development (Zhu et al., 2002).By conjugating the specific binding peptides of the αβintegrin to a 3D synthetic hydrogel substrate, we have seen robust formation of interconnected vascular-like ECs network of BMECs in 3D culture in the hydrogel, suggesting the utilities of the integrin type-specific binding peptides as functionalizing agents for biomaterials to promote the angiogenic phenotype of BMECs.Pairing of integrins on EC cell surface and the ligands that are present within the environment of ECs are important for promoting sprouting and vascular-like network formation of ECs during angiogenesis.
Direct research on characterizing function-specific integrin expression profile on cells is limited.Our integrin-binding array provides a valuable platform for the identification of specific types of integrins on BMEC surfaces that are responsible for mediating the key EC function in angiogenesis.The binding peptides to the identified types of integrins that mediate specific cell functions can be readily conjugated to biomaterial implants or 3D cell culture substrates to promote cell function of interest.Revascularization or angiogenesis in injured/diseased brain is critical for basic research,disease modeling, drug screening, and tissue regeneration in the context of related insults.Prospectively, as a continuation of this study, the binding peptides to the identified types of integrins that mediate angiogenesis of BMECs and neurogenesis of neural stem cells (NSCs) may be co-conjugated to transplantable hydrogel substrates to integrate both angiogenesis and neurogenesis for functional brain tissue regeneration.A 3D hydrogel system that is functionalized with the integrin binding peptides to direct both angiogenesis and neurogenesis of BMECs and NSCs in co-culture orin vivo
would allow interplay and self-assembly of vascular structures and neuronal cells through cell-cell adhesion, cell-ECM adhesion, and cell-cell signaling, promoting the formation of complete vascular-like structures to support the rewiring of neural networks.Close association of angiogenesis and neurogenesis during brain tissue repair has been documented following brain trauma and different types of neurological insults including cerebral stroke in which angiogenic blood vessels serve as a physical scaffold for neuron migration to the ischemic core (Wang et al., 2019; Yue et al., 2020).In addition, suppression of angiogenesis significantly hindered the migration of neural progenitor cells to the ischemic region (Iadecola, 2017).An accumulating body of evidence reveals the change of integrin expression profile on ECs under pathological conditions (Rocha et al., 2018; Hou et al., 2020) as well as during development (Milner and Campbell, 2002).The unique capability of our integrin-binding array platform to identify the specific types of integrins and their binding peptides that mediate the specific function of cells of interest under the condition of interest (e.g., healthyvs.
trauma or pathological) at the developmental stage of interest would help to customize biomaterials with key integrin-binding ligands as bioactive cues to orchestrate the interplay of distinct biological processes (e.g., therapeutic angiogenesis, neurogenesis, or tissue repair) for specific biomedical purposes.In addition to mediating cell interaction with ECM and the environment,integrins directly bind to several growth factors including a number of VEGF isoforms and VEGF receptors.In our 3D culture of BMECs in αβ-binding peptide-conjugated hydrogel that was supplemented with VEGF, the master regulator of angiogenesis (Hoeben et al., 2004), robust formation of 3D interconnected lumenized vascular-like network of BMECs was observed,which was absent in the control hydrogel groups with αβ-binding peptide without VEGF or with VEGF but without integrin binding peptide.The αβintegrin binding may amplify angiogenic signals in VEGF-induced vascular sprouting and drive lumenized vascular-like network formation (Li et al.,2017).Despite beyond the scope of the present study, a previous study demonstrated that when implanted subcutaneously in mice, αβintegrinmodified hydrogels supplemented with control-released VEGF promoted vessel sprouting and non-tortuous uniform vessel network formation typical of the normal mouse skin vasculature within the hydrogels while reducing VEGF-induced vascular permeability (Li et al., 2017).Our observation and the literature suggest the potential of integrin-specific biomaterials in conjunction with VEGF in dictating vascular patterning/morphogenesis and permeability bothin vitro
andin vivo
for therapeutic angiogenesis.This study is limited toin vitro
.In vivo
study is needed to confirm that the identified three specific types of integrins and their binding peptides can stimulate brain endothelial cell growth and new vessel formation to facilitate brain regeneration process.In conclusion, we assessed the growth of BMECs in different conditions and identified three specific types of integrins (α5β1, αvβ5 and αvβ8) and their binding peptides that are most supportive for adhesion and growth of BMECs in this study.These integrin binding peptides support a robust growth of BMECs and their formation of lumenized interconnected vascular-like network in 3D culture in the hydrogel.
Author contributions:
Methodology, investigation, data curation, formal analysis, writing – original draft: RK.Conceptualization, methodology,resources: XW.Conceptualization, writing – review & editing: NZ.Conceptualization, writing – review & editing, project administration, funding acquisition, supervision: DS.All authors approved the final version of the manuscript.
Conflicts of interest:
The authors declare no conflict of interest associated with the studies presented in this manuscript.Editor note: DS is an Editorial Board member of Neural Regeneration Research.She was blinded from reviewing or making decisions on the manuscript.The article was subject to the journal’s standard procedures, with peer review handled independently of this Editorial Board member and their research groups.
Open access statement:
This is an open access journal, and articles are distributed under the terms of the Creative Commons AttributionNonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.